Theranica Announces Landmark Coverage Milestone as Nerivio® Exceeds Half of the U.S. Insured Population
158 million covered lives nationwide bring the FDA-cleared wearable Remote Electrical Neuromodulation (REN) device to coverage parity with leading prescription migraine drugs, following a wave of recent payer coverage expansions. BRIDGEWATER, N.J. and CAESAREA, Israel, July 9, 2026...
158 million covered lives nationwide bring the FDA-cleared wearable Remote Electrical Neuromodulation (REN) device to coverage parity with leading prescription migraine drugs, following a wave of recent payer coverage expansions. BRIDGEWATER, N.J. and CAESAREA, Israel, July 9, 2026...
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.